Disclosure of clinically actionable genetic variants to thoracic aortic dissection biobank participants

BACKGROUND: Disclosure of pathogenic variants to thoracic aortic dissection biobank participants was implemented. The impact and costs, including confirmatory genetic testing in a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory, were evaluated. METHODS: We exome sequenced 240...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Med Genomics
Main Authors: Beil, Adelyn, Hornsby, Whitney, Uhlmann, Wendy R., Aatre, Rajani, Arscott, Patricia, Wolford, Brooke, Eagle, Kim A., Yang, Bo, McNamara, Jennifer, Willer, Cristen, Roberts, J. Scott
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7923508/
https://ncbi.nlm.nih.gov/pubmed/33648514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12920-021-00902-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados